On August 31, 2015 15:52 (IST)
Aurobindo Pharma shares jumped as much as 3.3 per cent to hit intraday high of Rs 779.70 after the company got approval from the US Food and Drug Administration (USFDA) to manufacture and market generic version of Eli Lilly's Evista tablets used for treatment of osteoporosis in post-menopausal women.
On August 14, 2015 12:16 (IST)
Stocks that will become a part of the MSCI India index, or those whose weightage is slated to go up, are likely to witness buying from passive funds which track the MSCI India index. Stocks which will be excluded from the index are likely to witness selling from passive funds.
On August 12, 2015 15:58 (IST)
Sun Pharma's revenue growth was driven by the Indian formulation business, which posted an annual growth of 11 per cent to Rs 1,784 crore and emerging markets business, which grew 10 per cent year-on-year to Rs 845 crore.
On July 21, 2015 19:26 (IST)
International brokerage house Jefferies said it is positive about Sun Pharmaceutical Industries' strong key fundamentals, though its stock plunged 15 per cent on Tuesday, a day after the company warned of a deeper cut in bottom line and topline this year due to its ongoing integration with Ranbaxy.
On July 21, 2015 14:51 (IST)
Indian shares were little changed in choppy trading on Tuesday as investors remained focussed on corporate earnings, while Infosys issued an upbeat outlook and Sun Pharmaceutical Industries warned on 2016 sales.
On July 21, 2015 23:10 (IST)
Analysts estimate a roughly 8-10 per cent hit to profit for the year as Sun Pharma struggles to fix manufacturing problems at one of its own key plants and those of Ranbaxy Laboratories, the troubled rival it bought last year.
On July 21, 2015 10:25 (IST)
Shares of Sun Pharmaceutical Industries slumped as much as 16 per cent to Rs 799 on Tuesday after India's largest drugmaker issued an earnings warning.
On June 01, 2015 16:39 (IST)
Sun Pharmaceutical shares fell over 8 per cent on Monday following the drugmaker's disappointing quarterly results in the March quarter. Sun Pharma, India's largest drugmaker by sales, had posted its Q4 numbers post market hours on Friday.
On May 15, 2015 11:37 (IST)
Sun Pharma is India's largest drugmaker.
On April 22, 2015 13:00 (IST)
The shares of Sun Pharma slumped 10 per cent in trades on Tuesday after Japan's Daiichi Sankyo sold its 8.9 per cent stake in India's biggest drugmaker at a discount.
On April 22, 2015 12:17 (IST)
The company was clarifying on speculations that Mr Sanghvi, who holds 9.61 per cent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.
On April 22, 2015 08:46 (IST)
The Nifty is likely to open lower on Wednesday tracking lacklustre cues from the global markets. Foreign investors bought shares worth Rs 17,489 crore on Tuesday, but this amount includes purchases of Sun Pharma shares sold by Japan's Daiichi Sankyo, which exited the company.
On April 21, 2015 21:34 (IST)
Daiichi which had forayed into the Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, today sold over 21 crore shares in Sun Pharma.
On April 21, 2015 09:45 (IST)
Shares of Sun Pharmaceutical Industries slumped over 10 per cent to hit intraday low of Rs 938 after Daichi Sankyo planned to sell 8.9 per cent stake in Sun Pharma.
On April 21, 2015 12:13 (IST)
Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Sun Pharmaceutical Industries.
On April 09, 2015 14:28 (IST)
Shares of Sun Pharma fell nearly 4 per cent to hit low of Rs 1,116 after Bank of America Merill Lynch downgraded the stock to 'underperform' from 'buy'.
On March 25, 2015 14:40 (IST)
Shares have retreated since hitting record highs early this month, as analysts warned about waning momentum and low trading volumes ahead of the end of the fiscal year at the end of March.
On March 24, 2015 16:20 (IST)
Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal between the companies.
On March 24, 2015 16:34 (IST)
The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net buyers to the tune of Rs 404 crore in cash market. Trading volume declined on Monday; cash segment ...
On March 10, 2015 16:35 (IST)
The trading volumes in the month so far has been very high; on Monday as many as 6 million shares of SPARC changed hands on the BSE.